Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Fact from yesterday’s RNS:-
The continued positive safety profile of AVA6000 at these dose levels compared with standard doxorubicin is remarkable. We are seeing a significant reduction in the incidence and severity of all doxorubicin side effects. Analysis of the tumour biopsies to date also confirms that enough doxorubicin is being released in the tumour to have a therapeutic effect. If even higher doses of AVA6000 are tolerated then this may make a significant difference to the outcomes for patients in the upcoming efficacy study.
# Best of British
As Shaun Chilton stated below on Monday he was well aware of Avacta’s ‘Very significant potential’ 🚀
Shaun Chilton, Non-Executive Director of Avacta Group, commented:
"Avacta Group is building a high value, global business that is seeking to significantly improve people's health and well-being. I am excited to leverage my own broad experience of growing healthcare businesses and working with the other members of the Board to help guide Avacta to meet its very significant potential."
Avacta's Diagnostics Division develops and supplies a broad range of in-vitro diagnostic (IVD) solutions. The Division is growing rapidly through an M&A strategy to deliver a global scale IVD business providing market leading solutions for healthcare professionals and consumers to inform treatment and monitor health and well-being.
Hope this doesn’t affect the death spiral ☠️
The Company is significantly advanced in relation to raising further capital. In addition, Dr Ian Campbell (Tlou's largest shareholder) has offered a $2m loan to the Company if required. The exact terms of the loan are being finalised. Subject to any regulatory approval the agreement is expected to be signed in the coming days. Once the agreement is executed the funds will be available to draw down immediately if necessary.
If the good doctor is happy to loan $2m then I can only see that as another positive sign.